Both in Biotechnology
Cardiff Oncology vs MiNK Therapeutics
Over the past year CRDF returned −62.6% and INKT returned −19.8%; their daily moves had a correlation of 0.11.
CRDF −62.6% INKT −19.8%Growth of $1, one year, split-adjusted
| Metric | CRDF | INKT |
|---|---|---|
| Price | $0.8631 | $10.79 |
| Market cap | $67.1M | $55.1M |
| Today | +2.23% | −2.26% |
| 1 month | −24.3% | −11.6% |
| 6 months | −46.4% | −6.5% |
| Year to date | −69.3% | −3.2% |
| 1 year | −63.3% | −23.1% |
| Revenue growth (YoY) | −14.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −8882.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 132.2× | — |
| Net cash | $34.5M | $8.8M |
| Dividend yield | — | — |
| Volatility (60d) | 71.6% | 51.1% |
| Short % of float | 17.7% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).